Actavis, Inc. (the manufacturer of several drugs, including a form of generic Reglan) recently tried to convince the U.S. Court of Appeals that federal law does not allow people injured by their drug to file a "failure-to-warn" claim against the drug maker.  In other words, Actavis, Inc., isn't wholly denying that their drug may cause Tardive Dyskinesia, and they disagree with people who suggest that their generic form of Reglan is being marketed with inadeqaute warnings about the possible harmful side-effects.

They U.S. Court of Appeals doesn't agree with Actavis's argument and has ruled in favor of people injured by the generic form of Reglan.  This is bad news for Actavis, Inc. and good news for the people who were misled by the drugmaker's poor efforts at warning about the serious side-effects that can occur.    

Actavis's drug is the generic form of Reglan, which is used to treat people who suffer from various gastrointestinal disorders.  Several people who have been injured by the drug have filed Reglan lawsuit claims against the manufacturer claiming that the side effects have caused symptoms that include:

• Involuntary and repetitive facial movements such as lip smacking, blinking, tongue clicking and thrusting, and lip movements
• Involuntary movement in the fingers, hands, toes, feet, arms, legs, shoulders, and trunk
• Difficulty walking, talking, breathing, and swallowing